Curevo Vaccine’s Steve Reed, PhD, Scientific Advisory and Executive Board member, and Lisa Shelton, ARNP, Associated Director Clinical Operations,  will be presenting at World Vaccine Congress Wednesday, September 30 @ 4:50pm EST/1:50pm PST , on Low side-effect safety profile demonstrated in phase 1 trial of shingles vaccine candidate CRV-101.  Join us to hear about the safety and a sneak peek into the humoral immunogenicity data.

Link to virtual conference here

Leave a Reply

%d bloggers like this: